The Drop of Allergen Immunotherapy for Respiratory Allergy in Italy: An Assessment of Sales
Year: 2025
Type: article
Abstract: Summary Allergen immunotherapy sales in Italy experienced a sharp decline between 2008 and 2016, followed by a more gradual decrease through 2023. Differences in reimbursement, along with structural, educational, and regulatory factors, likely contributed to the decline, and warrant further research.
Source: Clinical & Experimental Allergy
DOI: 10.1111/cea.70183
Authors: Mattia Giovannini, Antonio Bognanni, Simona Barbaglia, Luisa Brussino, Cristiano Caruso, Francesco Catamerò, Domenico Gargano, Enrico Heffler, Giovanni Paoletti, Giorgio Walter Canonica
Institutions: Meyer Children's Hospital, University of Florence, Humanitas University, IRCCS Humanitas Research Hospital, A. O. Ordine Mauriziano di Torino, University of Turin, Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico, Azienda Ospedaliera S.Giuseppe Moscati
Language: English
Subfield: Immunology and Allergy
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,760
Funder: Allergy Therapeutics
OpenAlex ID: W4417076314